Results 171 to 180 of about 214,324 (306)
Abstract Background Clinical outcome assessments (COAs) are essential for evaluating symptom severity, treatment response, and disease progression in Parkinson's disease (PD). As clinical knowledge evolves, it is necessary to revisit the recommendation status on the COAs to ensure their continued relevance and validity. Objectives To provide an updated
Evita Papathoma +14 more
wiley +1 more source
Navigating sleep apnea in Scandinavia - a journey of contrasts. [PDF]
Steen L +4 more
europepmc +1 more source
The Hidden Burden of Hemifacial Spasm: A Systematic Review of Non‐Motor Symptoms
Abstract Background Hemifacial spasm (HFS) is a chronic neurological disorder characterized by involuntary contractions of facial muscles. Traditionally regarded as a motor condition, HFS encompasses a spectrum of non‐motor symptoms that are often overlooked but significantly affect patients’ quality of life.
Miriam Carvalho Soares +2 more
wiley +1 more source
Redefining Obstructive Sleep Apnea: Treatment in the Modern Era. [PDF]
Redondo J, Ascher KB, Abreu AR.
europepmc +1 more source
ABSTRACT Circadian rhythms orchestrate cardiovascular physiology by regulating immune and inflammatory pathways. Disruption of these rhythms profoundly alters vascular homeostasis, thereby promoting the onset and progression of cardiovascular diseases (CVD).
Tian Zhang +22 more
wiley +1 more source
Effect of obstructive sleep apnea-hypopnea syndrome on myocardial mechanics in obese patients. [PDF]
Kang X +6 more
europepmc +1 more source
Abstract Background Although clinical markers (eg, motor and cognitive impairment) in isolated rapid eye movement sleep behavior disorder (iRBD) are associated with faster phenoconversion, their longitudinal trajectory patterns (linear or nonlinear) remain unclear.
Li Zhou +17 more
wiley +1 more source
Electrocardiographic assessment in obstructive sleep apnea: bridging pathophysiology and clinical practice. [PDF]
Roche F, Roux M, Benali K, Pichot V.
europepmc +1 more source
ABSTRACT Objective This study aimed to evaluate whether reduced‐frequency dosing of GLP1 receptor agonists maintains weight loss, body composition, and metabolic syndrome improvements following successful initial treatment with standard weekly therapy. Methods This retrospective case series included 30 adults who achieved weight plateau while on weekly
Michelle Wong +3 more
wiley +1 more source
Genetic insights of sleep apnea symptomatology and endotypes. [PDF]
Ollila HM.
europepmc +1 more source

